The Merck Foundation Company Profile

18:27 EDT 22nd September 2018 | BioPortfolio

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company and is Merck’s chief source of funding support to qualified non-profit charitable organizations. Since its inception, the Merck Foundation has contributed more than $870 million to support important initiatives that address societal needs and are consistent with Merck’s overall mission to help the world be well. For more information, visit

News Articles [1398 Associated News Articles listed on BioPortfolio]

CDx for Keytruda to be developed by Merck, Foundation Medicine

Foundation Medicine and Merck agreed to partner on the creation of companion diagnostic tests for Merck's anti-PD-1 immunothe -More- 

Merck, Foundation Medicine form immuno-oncology companion diagnostics collaboration

Merck has partnered with Foundation Medicine to develop a pan-cancer companion diagnostic for its Keytruda immunotherapy.

Merck Foundation Calls for Action to Break the Infertility Stigma in Africa at FIGO

DUBAI, UAE, April 14, 2018 /PRNewswire/ -- Merck Foundation engages policymakers to define interventions to improve access to regulated and cost effective Fertility Care in Africa and Developing C...

Foundation Medicine and Merck Enter Immuno-Oncology Companion Diagnostics Collaboration

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. (NASDAQ:FMI) today announced a collaboration with Merck, known as MSD outside the United States and Canada, to develop companion...

Merck, Foundation Medicine to build companion diagnostics for Keytruda

Companies to create tests for tissue-agnostic MSI-H and dMMR cancers using Foundation’s next-generation sequencing platform.

Roche’s buyout of Foundation Medicine: reaping benefits from Merck’s Keytruda

On June 19, pharma giant Roche announced plans to buy out the remainder of the leading next-generation sequencing (NGS) company,...Read More... The post Roche’s buyout of Foundation Medicine: reapin...

TMC, Merck join hands to train African oncologists to fill gap in cancer care

The Tata Memorial Centre (TMC), a premier centre of excellence in cancer care in India and Merck Foundation, a not for profit organisation of pharmaceutical major Merck have joined hands to train Afri...

Merck Ventures: Success in funding early innovation

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core busi...

Drugs and Medications [487 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [234 Associated PubMed Articles listed on BioPortfolio]

Winners of the Emanuel Merck Lectureship and the Heinrich Emanuel Merck Award.

Treating MS without continuous immunosuppression: an interview with Luciano Rossetti.

Luciano Rossetti, MD, Executive Vice President, Global Head of R&D at Merck KGaA, Darmstadt, Germany speaks to Laura Dormer, Commissioning Editor Luciano Rossetti, MD, is Executive Vice President, Glo...

The Florence Nightingale Foundation: developing nursing's leaders.

Ursula Ward, Chief Executive, Florence Nightingale Foundation, , describes the role of the foundation and its plans for the future.

Merck vaccine heads Ebola countermeasures.

Comments on Feskanich et al.: Milk and other dairy foods and risk of hip fracture in men and women.

Clinical Trials [339 Associated Clinical Trials listed on BioPortfolio]

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals' trivalent MMR (Priorix®), comparing it to Merck's MMR vaccine (M-M-R®II), which is approved for...

Study of EMD531444 in Subjects With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Darmstadt, Germany, June 17 2010 - Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome ...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Glucophage Extended Release (GXR) China Bioequivalence Study (Nantong - Darmstadt)

The study will assess the bioequivalence between single doses of GXR manufactured in Merck Nantong China (test drug) and GXR manufactured in Merck Darmstadt Germany (reference drug) under ...

Glucophage® Extended Release (XR) 750 Milligram (mg) Indonesia Bioequivalence (BE) Study

The purpose of this study is to assess bioequivalence between metformin hydrochloride (Glucophage® XR) manufactured in PT Merck Tbk, Indonesia (test drug) and metformin hydrochloride (Glu...

Companies [1502 Associated Companies listed on BioPortfolio]

Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

The Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

Merck & Co

Here you will find an overview of our activities in the core businesses of pharmaceuticals and chemicals. We illustrate the structure of our company. We present the Executive Board of Merck KGaA. ...

Merck Animal Health

Today's Merck is a global healthcare leader working to help the world be well. Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global ...

Merck Serono

Merck Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono ...

More Information about "The Merck Foundation" on BioPortfolio

We have published hundreds of The Merck Foundation news stories on BioPortfolio along with dozens of The Merck Foundation Clinical Trials and PubMed Articles about The Merck Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Merck Foundation Companies in our database. You can also find out about relevant The Merck Foundation Drugs and Medications on this site too.

Quick Search


Relevant Topics

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Corporate Database Quicklinks

Searches Linking to this Company Record